Jun
2026
Shanghai New International Expo Center
Visit us
stand E1C17, Pharma Ingredients

MFC Co., Ltd.

Exhibitor at CPHI & PMEC China 2026
About Us

MFC Co., Ltd., established in 2008, is a manufacturer specializing in APIs and key intermediates that GMP from the Korean Ministry of Food and Drug Safety (KMFDS) and AFM from PMDA are approved. MFC is continuously developing under quality Management through thorough quality control and quality assurance system, and technology management that puts best efforts in continuous process management and new technology development. MFC’s direction and aim are the development of excellent new APIs and key intermediates, and CMO/CDMO business in accordance with customer requirements, and incrementally Modified Drugs (IMD) & New Chemical Entity (NCE) using specialized technologies to go forward as a global pharmaceutical company. Especially, MFC is specialized in Pitavastatin & Rosuvastatin for prescription of hyperlipidemia.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Generic APIs producer
View company profile
Contact info
  • +82-31-8059-8295
  • 35, Cheongwonsandan 7-gil, Mado-myeo, Hwaseong-si, Gyeonggi-do, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E1C17, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • Synthesis of APIs

    Product Synthesis of APIs

    APIs:  Pitavastatin Calcium Hydrate, Rosuvastatin Calcium, Donepezil, Clopidogrel Bisulfate, Sarpogrelate Hydrochloride, Erdosteine, Pelubiprofen, (S)-Amlodipine Besylate 2.5 Hydrate, (S)-Pantoprazole Sodium Trihydrate

    Intermediates of Statins:
    MRV-1, ...
  • TBFA

    Product TBFA

    High purity target compounds in solid phase (amorphous/crystalline form) rather than oil phase.

    Detailed technologies: 1) High-purity synthesis technology 
    2) Separation and purification technology            
    3...

MFC Co.,Ltd. Resources (1)

  • MFC Co.,Ltd

    Video MFC Co.,Ltd

    MFC Co., Ltd., established in 2008, is a manufacturer specializing in APIs and key intermediates, which GMP certified from KMFDS. MFC is continuously developing under quality management through thorough quality control and quality assurance system, and technology management that put best efforts in continuous process improvement and new technology development. MFC's direction and aim are the development of new excellent new APIs and intermediates, CMO/CDMO business in accordance with customer requirements, and Incrementally Modified Drugs (IMD) & New Chemical Entity (NCE) using specialized technologies to go forward as a global pharmaceutical company.
    2024-09-23